The Faculty of Medicine: Innovation Changing Lives
At the Hebrew University’s Faculty of Medicine, Israel’s most brilliant medical and scientific minds are working together to unlock the mysteries of the genes and proteins that control fundamental processes in living cells. They are creating treatments and drug therapies to ameliorate and prevent disease, training the next generation of compassionate medical specialists, and sharing knowledge with students from around the world.
In a new study, Hebrew University researchers collaborated with colleagues from Israel and abroad to develop a novel device that absorbs light and stimulates neurons without using wires or external power sources.More
The Liddy Shriver Sarcoma Initiative has partnered with the Alan B. Slifka Foundation to fund promising osteosarcoma research being conducted by Prof. Rami Aqeilan of the Lautenberg Center for Immunology and Cancer Research and the Institute for Medical Research Israel-Canada in the Faculty of Medicine to explore pre-treatment biomarkers of osteosarcoma metastasis and their responsiveness to therapy.More
This year’s Israel Prize for Medicine will be awarded to Prof. Marta Weinstock-Rosin of the School of Pharmacy-Institute for Drug Research at the Faculty of Medicine in recognition of her achievements in the development of pharmaceutical treatments for the symptoms of neurodegenerative diseases. She is best known for the development of Exelon, an effective treatment for confusion and dementia related to Alzheimer's and Parkinson's diseases.More
The 2013 Abisch Frenkel Prize for Excellence in Life Sciences has been awarded to Prof. Yuval Dor of the Faculty of Medicine's Institute for Medical Research Israel-Canada. Dor, recognized for his outstanding research and its impact on pancreatic cancer and diabetes, hopes to harness his findings to develop novel treatment approaches.More
Building on a longtime discovery by the Lautenberg Center's Prof. Yinon Ben-Neriah and University alumnus and Nobel Laureate Prof. Aaron Ciechanover, an international team has discovered a possible therapy for alleviating mucositis, an inflammatory condition that is a common side-effect of chemotherapy and irradiation. Doctoral student Naama Kanarek, a member of Ben-Neriah’s lab, traced mucositis' pathological basis and discovered an antibody which could potentially prevent its onset.More